Light source for eye therapy and light emitting device having the same

US11213693B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11213693-B2
Application numberUS-201916394850-A
CountryUS
Kind codeB2
Filing dateApr 25, 2019
Priority dateApr 27, 2018
Publication dateJan 4, 2022
Grant dateJan 4, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A light source for eye therapy configured to emit light having a wavelength range from about 380 nm to about 780 nm, and has a spectrum area that overlaps at least about 55% of an area of a normalized solar spectrum, in which a peak wavelength of light has a deviation equal to or less than about 0.14 from the normalized solar spectrum in a wavelength range from about 380 nm to about 490 nm.

First claim

Opening claim text (preview).

What is claimed is: 1. A light source for eye therapy configured to emit light having a wavelength range from 380 nm to 780 nm, and has a spectrum area that overlaps at least 55% of an area of a normalized solar spectrum, wherein: a peak wavelength of the light has a deviation equal to or less than 0.14 from the normalized solar spectrum in a wavelength range from 380 nm to 490 nm; a color temperature of the light is in a range of 2600K to 7000K; and the deviation of the peak wavelength of the light increases as the color temperature of the light increases from 2600K to 4000K. 2. The light source of claim 1 , wherein a valley wavelength of the light has a deviation equal to or less than 0.15 from the normalized solar spectrum in the wavelength range from 460 nm to 490 nm. 3. The light source of claim 2 , wherein the spectrum area of the light overlaps at least 55% of the area of the normalized solar spectrum when the color temperature of the light is in a range of 2600K to 3700K. 4. The light source of claim 3 , wherein a peak wavelength of the light has a deviation equal to or less than 0.10 from the normalized solar spectrum. 5. The light source of claim 2 , wherein the spectrum area of the light overlaps at least 70% of the area of the normalized solar spectrum when the color temperature of the light is in a range from 3700K to 4700K. 6. The light source of claim 5 , wherein the peak wavelength of the light has the deviation equal to or less than 0.13 from the normalized solar spectrum. 7. The light source of claim 2 , wherein the spectrum area of the light overlaps at least 75% of the area of the normalized solar spectrum when the color temperature of the light is in a range from 4700K to 7000K. 8. The light source of claim 7 , wherein the peak wavelength of the light has the deviation equal to or less than 0.14 from the normalized solar spectrum. 9. A light source for eye therapy, configured to emit light having a color temperature in a range of 2600K to 7000K, wherein: a spectrum area of the light overlaps at least 55% of an area of a normalized solar spectrum; a peak wavelength of the light has a first deviation from the normalized solar spectrum in a wavelength range from 380 nm to 490 nm; a valley wavelength of the light has a second deviation from the normalized solar spectrum in the wavelength range from 380 nm to 490 nm that is equal to or greater than the first deviation; and a difference between the first deviation and the second deviation decreases as the color temperature of the light increases from 3000K to 5000K. 10. The light source of claim 9 , wherein the peak wavelength of the light has the first deviation equal to or less than 0.14 from the normalized solar spectrum. 11. The light source of claim 9 , wherein the normalized solar spectrum is represented by E ⁡ ( λ , T ) = 2 ⁢ hc 2 λ 5 · 1 e hc / λ ⁢ ⁢ kT - 1 , where λ, h, c, T, and k denote a wavelength (um), Planck's constant, a speed of light, an absolute temperature, and Boltzmann's constant, respectively. 12. The light source of claim 11 , wherein the light source is used for treating myopia. 13. The light source of claim 11 , wherein the light source is used for reducing eye stress. 14. A light emitting device for eye therapy, comprising: the light source of claim 9 ; and a control unit for controlling the light source. 15. The light emitting device of claim 14 , further comprising a mounting member connected to the light source to be mounted on a user's head. 16. The light emitting device of claim 14 , further comprising a supporting member for supporting the light source to be provided as a table lamp. 17. A light emitting diode for eye therapy, comprising: a first light source configured to emit light having a first wavelength range from 380 nm to 780 nm, wherein a spectrum area of the light overlaps at least 55% of an area of a normalized solar spectrum; a second light source configured to emit light in a ultraviolet wavelength range; a location information receiving unit configured to detect a location of the light emitting diode; and a control unit configured to adjust an amount of the light emitted from the first and second light sources in response to information obtained from the location information receiving unit, wherein: a peak wavelength of the light emitted from the first light source has a deviation equal to or less than 0.14 from the normalized solar spectrum in a wavelength range from 380 nm to 490 nm; a color temperature of the light emitted from the first light source is in a range of 2600K to 6500K; and the deviation of the peak wavelength has the greatest value when the light emitted from the first light source has the color temperature of 6500K. 18. The light emitting diode of claim 17 , further comprising a third light source configured to emit light in an infrared wavelength range, wherein the location information receiving unit comprises a global positioning system. 19. The light emitting diode of claim 18 , wherein a peak wavelength of the light emitted from the first light source has a deviation equal to or less than 0.14 from the normalized solar spectrum in a wavelength range from 380 nm to 490 nm, and a valley wavelength of the light emitted from the first light source has a deviation equal to or less than 0.15 from the normalized solar spectrum in the wavelength range from 450 nm to 530 nm.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11213693B2 cover?
A light source for eye therapy configured to emit light having a wavelength range from about 380 nm to about 780 nm, and has a spectrum area that overlaps at least about 55% of an area of a normalized solar spectrum, in which a peak wavelength of light has a deviation equal to or less than about 0.14 from the normalized solar spectrum in a wavelength range from about 380 nm to about 490 nm.
Who is the assignee on this patent?
Seoul Viosys Co Ltd
What technology area does this patent fall under?
Primary CPC classification A61N5/06. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).